New heart product - Atenolol Jadran

We added a new product to our line of cardiovascular drugs, a selective β-blocker ATENOLOL JADRAN.

Atenonolol's long-term administration in clinical practice for the treatment of hypertension, angina, heart arrhythmia and myocardial infarction has made it a synonym for the entire β-blocker group.

Atenolol Jadran is on the CIHI primary list of drugs.



tablets 30 x 50 mg

20 x 100 mg

To make this website run properly and to improve your experience, we use cookies. For more detailed information, please check our Privacy and personal data protection.

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.